Abstract
Renal artery duplex ultrasonography (RADUS) is a non-invasive, safe, inexpensive and accurate method for assessing the renal arteries. Common uses for RADUS include diagnosis of renal artery stenosis (RAS) in patients with clinical clues suggestive of the disease; surveillance of patients with known native or transplant artery RAS; following renal artery stent revascularization; and for corroboration after suspicious findings are found by other imaging modalities. The RADUS examination includes spectral Doppler velocities obtained from the abdominal aorta at the level of the renal arteries, throughout the entire renal artery, and in the renal parenchyma. It is noteworthy that as the kidneys are located in the retroperitoneum, imaging of native renal arteries with RADUS requires a high degree of technical skill and extensive training. Due to this and several other inherent limitations, use of other imaging modalities should be considered to corroborate RADUS findings prior to intervention.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Renal artery stenosis
- Renal artery duplex ultrasonography
- Renal to aortic ratio
- Renal resistive index
- Renal artery stent revascularization
Introduction
Renal artery stenosis (RAS) is common and most often caused by aortic atherosclerosis which extends into the artery ostium. It is most prevalent in at-risk populations, such as patients with poorly controlled hypertension (HTN) [1] or among patients with coronary [2] and/or peripheral artery disease (PAD), where it has been found in up to 59 % of patients [3]. Potential clinical consequences of RAS include difficult to control hypertension, progressive renal dysfunction and cardiac disturbance syndromes (recurrent congestive heart failure, refractory angina and “flash” pulmonary edema) [4, 5].
Multiple diagnostic tools are at a clinician’s disposal when RAS is suspected. However, none surpasses an initial high index of suspicion based on a series of clinical “clues.” A clinical algorithm has resulted in sensitivity and specificity of 65 % and 87 %, respectively when compared to nuclear renal scintigraphy before and after an angiotensin converting enzyme inhibitor was administered [6]. However, radionucleotide studies often are difficult to interpret in patients with chronic kidney disease, and the technique cannot be used to identify RAS reliably if the patient has bilateral disease or if only one kidney is present. Furthermore, accuracy has not been consistent among studies [7]. Plasma renin activity in it of itself, even with captopril stimulation, has poor accuracy due to overlap in patients with primary HTN [8].
Modern non-invasive methods include renal artery duplex ultrasonography (RADUS), computed tomography angiography (CTA) and magnetic resonance angiography (MRA), while invasive methods consist of contrast angiography (CA), intravascular ultrasound and translesional pressure measurements [9]. This chapter will concentrate on the role of RADUS.
Common uses for RADUS include screening for RAS, surveillance of patients with native artery RAS or after renal artery stent revascularization, and for corroboration after suspicious findings are found by other imaging modalities [10]. Recently published “appropriate use criteria” suggest that RADUS is reasonable to consider when evaluating patients with HTN that is resistant, malignant, difficult to control or present in patients younger than 35 years; unexplained increase in creatinine or renal failure in conjunction with aortic dissection and in patients with either HTN or elevated creatinine and unexplained size difference >1.5 cm between kidneys or an epigastric bruit [11]. Interestingly, these same criteria suggest that RADUS was inappropriate to use as a screening tool in asymptomatic patients with atherosclerosis in other vascular beds. Choosing RADUS over other modalities should include consideration of its various advantages and disadvantages as outlined in Table 12.1.
Renal Artery Duplex Ultrasonography as an Epidemiological Tool
Although some small studies attempted to define the natural history of atherosclerotic RAS (ARAS) with a combination of CA and clinical surveillance, results have been heterogeneous [14]. Subsequently, similar attempts have been made with RADUS. Interpreting these studies should take into account the specific subjects studied as well as the exact manner by which events were defined. In an unselected sample of 750 Japanese patients with coronary, cerebrovascular or peripheral artery disease, ARAS was found in 40 by RADUS criteria and later confirmed by CA in 35 people [15]. Noting small numbers, sub-group analysis revealed ARAS to be most prevalent in patients with carotid and peripheral artery disease (20 %). Renal artery stenosis epidemiology has been studied further in the Cardiovascular Health Study, a longitudinal, population based cohort study of elderly outpatients [14, 16]. In 834 people in whom RAS ≥ 60 % was defined by peak systolic velocity (PSV) ≥ 180 cm/s, the prevalence was 6.8 % [16]. Prevalence of coronary artery disease was greater in patients with evidence of ARAS [17]. Follow up in 119 subjects 8 years later revealed that none of the patients previously diagnosed with ARAS progressed to renal artery occlusion and that new RAS was found in 9 of the 235 analyzed renal arteries [14]. Disease progression, defined as an increase in PSV greater than 2 standard deviations in the cohort (≥45 cm/s), occurred in 29 renal arteries. In another study that examined ARAS in 170 hypertensive patients, RAS progression was defined as an increase in PSV > 100 cm/s and occurred in 31 % over 5 years [18]. In another study 76 patients were prospectively followed over 3 years and anatomic progression was found in 20 % [19]. However, in this study RAS ≥ 60 % was defined by a combination of PSV ≥ 180 cm/s and RAR > 3.5. Thus, patients who had PSV ≥ 180 cm/s at the beginning of the study, but did not meet the RAR criterion, were not defined as having significant RAS. It is noteworthy that this study also reported 7 % of subjects progressed to occlusion.
Technique for Performance of Renal Artery Duplex Ultrasonography
As the kidneys are located in the retroperitoneum, imaging of native renal arteries with RADUS requires a high degree of technical skill and extensive training. In our vascular diagnostic laboratory, we have the following requirements for a technologist to perform RADUS independently:
-
Hold the Registered Vascular Technologist (RVT) certification
-
Observe 50 RADUS examinations by a trained and experienced colleague
-
Attend an off-site 2-week hands-on training course specific to RADUS
-
Perform 50 sequential RADUS exams under direct observation by a trained and experienced colleague
-
Maintain documented ongoing proficiency in our regular quality assurance program
The RADUS examination includes spectral Doppler velocities obtained from the abdominal aorta at the level of the renal arteries, throughout the entire renal artery, and in the renal parenchyma [20]. The vascular testing division of the Intersocietal Accreditation Commission (ICAVL) has specified the minimum requirements for a complete RADUS examination (Table 12.2). Ideally, RADUS should be performed in the early morning hours after the patient has completed an overnight fast in order to minimize bowel gas overlying the renal arteries. Imaging is achieved from two approaches. First the aorta and renal arteries are interrogated from the supine, midline approach with the patient in the reverse Trendelenburg position. Subsequently, the patient is turned into the lateral decubitus position with the arm raised over the head in order to increase the imaging zone in the intercostal or subcostal space (Fig. 12.1a, b). In our vascular laboratory, we require that the entire renal artery from the ostium through the hilum of the kidney to be imaged and sampled in order to qualify as a complete examination. Interrogation of a transplanted renal artery and its related anastomosis to the inflow iliac artery is easier as it is typically more superficial.
A RADUS requires imaging equipment that includes low frequency (typically 2.25- to 4.0-MHz) curved linear- or phased array transducers. A vascular software package is also needed [20]. The examination begins with identification of the aorta in the sagittal plane throughout its length, assessing for an aneurysm or atherosclerosis while the patient is in the supine position. At the level of the renal arteries, the PSV is measured. The normal abdominal aortic PSV ranges from 40 to 100 cm/s. Next, the probe is rotated 90°, and each renal artery origin is located in the transverse plane (Fig. 12.2). The angle of insonation is maintained at 60° or less while imaging parallel to the direction of renal artery blood flow. Doppler spectral waveforms are obtained. The PSV is obtained in both renal arteries from the aortic origin to renal hilum. The presence of post-stenotic turbulence identified as the presence of as a chaotic Doppler spectral waveform with blunting of the peak of the waveform, should also be noted [21] (Fig. 12.3). This process is repeated from the flank approach (Fig. 12.4). A complete RADUS includes imaging of the kidney including maximal pole-to-pole renal length, demonstration of cortical, medullary and hilar blood flow and identification of associated findings such as cysts or masses (Figs. 12.5 and 12.6). Intrarenal sampling is performed at a 0° Doppler angle in the superior and inferior pole of the kidney, within the cortex and medulla.
Table 12.3 outlines common technical and interpretation errors in RADUS.
Native Renal Artery Duplex Ultrasonography
In a normal kidney, arterial flow is low resistance, demonstrating continuous flow during systole and diastole [22]. The two most common measures for assessing RAS are PSV and the ratio of the PSV as measured in the renal artery origin and the PSV in the aorta at the level of the renal artery, referred to as the renal aortic ratio (RAR). The RAR cannot be used when significant aortic disease is present (PSV > 100 cm/s) or in within an abdominal aortic aneurysm (PSV < 40 cm/s) [23].
Multiple studies have validated RADUS criteria for RAS, most often by comparison to CA as the “gold standard” (Table 12.4). Most have shown RADUS to have excellent sensitivity and specificity, most commonly reported to be above 80 %. An early retrospective analysis of 122 kidneys with single main renal arteries in 74 patients showed RADUS to have 93 % sensitivity, 98 % specificity, 98 % positive predictive value, 94 % negative predictive value, and an overall accuracy of 96 % as compared to CA [21]. The criteria that are most commonly used in clinical practice have been derived from a prospective, blinded study, in which 102 patients who were clinically suspected of having RAS underwent both RADUS and CA within 30 days of each other [44]. Using a PSV of ≥200 cm/s or a RAR of ≥3.5 resulted in sensitivity of 98 %; specificity 99 %; positive predictive value 99 %; and negative predictive value 97 %. Another retrospective comparison utilized the more accurate quantitative vessel analysis (QVA) method in 67 renal arteries, 34 of which demonstrated RAS ≥ 60 % [12]. Both PSV and RAR correlated with RAS; however, RAR was found to be more accurate by ROC curve analysis. More recently, several comparisons of RADUS derived criteria and estimated RAS as assessed by invasive translesional pressure gradients were performed. This method is considered to be more accurate in detecting hemodynamically significant RAS than visual estimation of degree of stenosis [53]. A first such study was performed in 75 renal arteries in 60 patients [25]. Renal artery DUS derived PSV demonstrated a sensitivity, specificity and accuracy of 89 %, higher than values derived for the RAR. A second comparison was performed in 56 renal arteries in 47 patients [12]. Analysis by receiver operator characteristic (ROC) curves showed that PSV > 318 cm/s, end-diastolic velocity >73 cm/s and RAR > 3.74 best corresponded to CA proven RAS > 50 %, while commonly accepted criteria (Table 12.5) resulted in false positive results, especially when compared to pressures gradients. A RADUS demonstrating RAS can be seen in Fig. 12.7. Renal artery occlusion, on the other hand, is diagnosed by lack of arterial flow coupled by flow detected in the ipsilateral renal vein.
The renal resistive index (RRI) is another measure obtained during a complete RADUS examination. This is an ultrasound-derived technique designed to evaluate the status of parenchymal renal arterial perfusion. Peak systolic velocity and end-diastolic velocity (EDV) obtained in branches of the renal artery at the level of the medulla are used to calculate the RRI [20]. It is an angle independent measurement obtained in both the superior and inferior poles of the kidney. The resistive index is calculated by the following equation: \( \left[1-\left(\frac{ EDV}{ PSV}\right)\right]\times 100 \) Thus, a lower RRI will theoretically suggest a “healthier” kidney (Fig. 12.8). Furthermore, according to one study, a RRI < 0.8 may suggest better clinical outcomes following renal revascularization [54], although this has been challenged by more recent publications [55]. Surprisingly, in two studies collectively examining 286 patients, the RRI was significantly lower in kidneys with RAS than in normal renal arteries [56, 57]. However, the RRI has questionable reliability. First, small measurement errors can result in significant changes in the calculated RRI. Also, conditions other than renal artery disease may affect the RRI. Examples include obstructive uropathy, hypotension, bradycardia and a peri-nephric fluid collection [22]. The RRI may have more utility in surveillance of transplanted kidneys [58].
Another approach is to calculate the difference in RRI between the two kidneys (ΔRRI). In a comparison of 40 CA proven normal renal arteries with 29 renal arteries with varying degrees of RAS, a ΔRRI > 0.05 was found to correlate with RAS > 50 % [57]. Another study comparing ΔRRI between 59 patients with RAS > 70 % and 155 patients with normal renal arteries also reported the ΔRRI to be significantly higher in patients with RAS [56]. All patients were hypertensive. A ΔRRI of 0.08 produced sensitivity of 92.5 % and specificity 97.5 % in a ROC curve analysis.
Other alternatives to PSV and RAR have been suggested. One such alternative is the acceleration time (AT), obtained from spectral analysis of Doppler waveforms from renal hilar vessels by means of a flank approach. The AT is a measure of waveform dampening. Theoretically, a longer AT points to a dampened waveform resulting from a more proximal stenosis. There are data to suggest that significant changes in renal artery waveform contour only occur with very severe stenosis [46]. Most studies have found AT to be useful in the detection of RAS (Table 12.4). Conversely, in a retrospective analysis of 76 kidneys in 41 patients, 51 of which had CA proven RAS > 60 %, hilar flow analysis has been reported to have lower sensitivity and accuracy as compared to conventional RADUS criteria [33].
Contrast enhanced DUS is another method that has been attempted with the purpose of simplifying the RADUS exam. Several seconds after injection of a contrast agent, it ultrasonographically enhances the arterial circulation for several minutes. Theoretically this should result in easier localization of the renal arteries and quicker acquisition of measurements. In a prospective comparison of conventional RADUS, contrast enhanced RADUS and CA in 21 hypertensive patients, examination time was shorter and sensitivity and specificity were improved for Acceleration <3.75 m/s2 when contrast was used [42]. In this context, acceleration referred to the slope of the line between the start of systole to the early systolic peak.
Other duplex derived methods for the diagnosis of RAS including the pulsatility index [59] and waveform analysis from the main renal artery [47, 60] have not proven to be useful clinically. Indirect imaging of the distal main renal artery or parenchymal branches, demonstrating a parvus et tardus waveform, is used by some as a criterion for a proximal stenosis. However, the accuracy of this method as a single data point is inferior to direct imaging of the main renal artery [39].
Recently several novel ultrasound-derived criteria have been reported. Power Doppler generates a color map that reflects the cumulative density of red blood cells within an examined volume of arterial blood. In a small study of nine patients power Doppler was found to be more sensitive and specific for RAS than conventional Doppler [61]. B-flow imaging (BFI) is a non-Doppler ultrasound technology that utilizes high frequency digital encoded sound waves to generate a real-time picture of blood flow in a display that resembles an angiogram [62]. In a comparison of BFI and RADUS in 51 patients with angiographically proven RAS > 50 %, the two techniques performed similarly. Sensitivity and specificity for BFI and PSV were 88 and 94 % and 100 and 71 %, respectively. Seven renal arteries were excluded because of excessive abdominal gas. Velocimetric waveform analysis is another technique that allows calculation of maximal acceleration (ACCmax) within early systole and the maximal acceleration index (AImax = ACCmax/PSV). Saeed et al. retrospectively examined the utility of these measures in 169 patients who underwent both angiography and duplex ultrasonography and found sensitivity and specificity for ACCmax to be 85 and 75 %, respectively and for AImax 83 and 79 %, respectively [63]. No direct comparison was made with PSV or RAR. Until larger prospective validation studies have been completed, we routinely use renal artery PSV and RAR as our main criteria for detecting RAS.
It should be noted that despite widespread clinical use of RADUS criteria that rely on these studies, they all suffer from the well-recognized limitation of verification bias. These studies have performed the comparison study (i.e., CA) based on the result of RADUS. When the reference standard procedure depends on the investigated test, a reliable estimate of diagnostic accuracy is precluded. Theoretically, to obtain valid accuracy estimates of RADUS criteria, all subjects should undergo both RADUS and CA regardless of preliminary RADUS results [64].
Another important note is the considerable variability between studies for similar measures (Table 12.4). This could theoretically be explained by variations in operator experience between studies; however, there are no data to support this hypothesis. Notwithstanding, in a meta-analysis the PSV was the most accurate parameter with sensitivity and specificity of 85 and 92 %, respectively [7].
Finally, RADUS has also demonstrated accuracy in the diagnosis and surveillance of renal artery fibromuscular dysplasia (FMD), albeit in a small series. It may identify the typical beaded appearance of the medial fibroplasia variant and suggest mid or distal artery involvement by PSV measurements [65, 66].
Ultrasound Surveillance Criteria Following Renal Artery Stent Revascularization
When discussing stented (as opposed to native) renal artery DUS, two issues should be mentioned. The first is the timing of surveillance after the procedure. While there are no prospective comparative studies, patients are usually followed within a month from the procedure, after 6 months and after 12 months and annually thereafter. It is noteworthy that the aforementioned appropriateness criteria denoted surveillance during the first year post-procedure as having uncertain value and found surveillance to be appropriate only after this interval [11]. The second issue is the choice of DUS criteria for in-stent restenosis (ISR). Theoretically, the DUS criteria for ISR may differ from those of native RAS because of altered arterial compliance and thus altered blood flow patterns [64]. Similar to native renal arteries, DUS criteria for renal ISR have been derived from comparisons of RADUS with CA and similarly different reports resulted in somewhat different values for both PSV and RAR in the diagnosis of ISR. Thus, in some publications both PSV and RAR are reported to be higher in ISR than in native RAS, while in others these values were actually lower. A retrospective analysis examined the value of PSV and RAR as compared to CA for detecting ISR > 50 % in 33 renal stents and found a PSV > 226 cm/s and a RAR > 2.7 to offer optimal ROC curves (sensitivity and specificity of 100 and 90 % and sensitivity and specificity of 100 and 94 % for PSV and RAR, respectively) [67]. In the RENAISSANCE trial, a prospective, single-arm, renal artery stenting study, an 86.6 % concordance was found between RADUS and CA in 30 lesions [68]. The RADUS criteria for ISR used to correlate with CA ISR ≥ 50 % were a RAR ≥ 3.5 or an absolute PSV ≥ 225 cm/s in association with post-stent turbulence. In another study, a retrospective analysis of 47stented renal arteries in 30 patients by using ROC curves, a PSV of 250 cm/s was associated with a sensitivity of 59 %, specificity of 95 %, an accuracy of 83 %, and a positive predictive value of 87 % [64]. Another retrospective comparison of PSV and RAR between 31 patients with angiographically proven ISR and 30 patients with angiographically proven native RAS suggested that a PSV of 395 cm/s and an RAR of 5.1 most valuable for detecting ISR ≥ 70 % (sensitivity of 83 %, specificity of 88 %, and accuracy of 87 % and sensitivity of 94 %, specificity of 86 % and accuracy of 88 %, for PSV and RAR, respectively) [69]. As there are no uniform criteria for renal ISR, before re-intervention is attempted clinicians should consider the clinical indications first (i.e., worsening blood pressure control or declining renal function) in conjunction with the abnormal DUS result and not act on just the abnormal DUS result alone [69].
Some controversy exists regarding RADUS criteria for covered renal stents (as opposed to bare-metal stents). To date, one retrospective analysis of prospectively collected data of addressed this matter by reporting DUS criteria for covered and uncovered renal artery stents placed in conjunction to endovascular repair of abdominal aortic aneurysms [70]. Six of 231 covered stents developed ISR and the authors reported that a PSV > 280 cm/s and a RAR > 4.5 resulted in optimal detection of these events, by comparing RADUS, CTA and CA findings.
Transplant Renal Artery Duplex Ultrasonography
Transplant RADUS is performed in order to identify pathology in the transplant kidney, artery, vein and collecting system. It is usually first performed soon after surgery and later routinely or based on patient clinical and biochemical characteristics. The discussion hereafter will focus on the transplant renal artery. As the renal transplant graft is usually placed extraperitoneally and superficially, most commonly in the right lower abdominal quadrant, use of a high frequency probe should be considered to achieve optimal visualization of structures [71]. The transplanted kidney arterial inflow anastomosis type depends on donor and recipient anatomy and may be end to end (EE) to the internal iliac artery or end to side (ES) with either the internal or, more commonly, the external iliac artery [72]. The IAC-vascular division guidelines for transplant RADUS are similar to those for native arteries (Table 12.2), with variations that include the need to examine the peri-transplant region with gray scale images, the arterial anastomosis with spectral Doppler waveforms and velocity measurements as well as the venous anastomosis with spectral Doppler waveforms [11]. It should be noted that as external iliac artery stenosis can result in impaired blood flow to the transplanted kidney, this artery should also be interrogated as part of a complete examination [73]. Furthermore, transplant renal arteries have two characteristics that may cause elevated PSV without stenosis. First, an ES anastomosis may result in local tortuosity and second, a transplant kidney tends to undergo hypertrophy and may be supplied by a higher than normal blood volume. Also, there is significant normal variability of PSV in transplant renal arteries [74]. Published PSV that have been shown to identify transplant RAS range between 150 and 300 cm/s [75–77]. These have relied on relatively small series. Other measures have therefore been added to supplement the PSV such as the AT and the renal artery: external iliac artery ratio (RIR), though considerable variability has been noted with these criteria as well [74]. A retrospective analysis of 38 transplant renal arteries with severe RAS, 19 representing each kind of anastomosis, was undertaken and revealed the AT to be similar between EE and ES types, while PSV was much higher in the EE type of anastomosis [72]. This analysis did not, however, have a control group and therefore could not assess for a cutoff for the diagnosis of RAS. A recent comparison of RADUS, MRA and CA was performed in 10 transplant renal arteries found to have CA proven RAS > 50 % and 12 arteries in patients in whom stenosis was not suspected clinically [73]. The best accuracy for RAS detection was achieved with PSV > 250 cm/s, AT > 0.1 s and RIR > 2. As a single measure, AT offered the best results, while RI did not differ between the groups. A PSV > 200 cm/s resulted in better sensitivity (90 % vs. 70 %). To further overcome the aforementioned physiologic changes in transplant renal artery blood flow a study of RADUS characteristics in 14 transplant renal arteries with CA proven stenosis ≥80 % used a ratio of the renal artery PSV to the PSV in the interlobar renal arteries >13 as a discriminator [78]. Finally, the intraparenchymal AT was significantly longer when RAS was present in a comparison between 15 transplant renal arteries without stenosis and 4 arteries with RAS > 50 % [79].
Other Findings on RADUS
As stated, a complete RADUS should include bilateral visualization of the entire length of the renal artery and also of the kidney parenchyma. In a prospective surveillance of 101 kidneys for an average of 14.4 months, 26 % of 49 kidneys with RAS > 60 % demonstrated >1 cm length reduction, while atrophy was absent in all other patients [80]. In another prospective surveillance of 204 kidneys over a mean of 33 months renal atrophy, defined as 1 cm length reduction, occurred in 20.8 % of patients with RAS ≥ 60 %, more than in patients with normal or less severe stenosis (5.5 % and 11.7 %, respectively, P = 0.009) [81]. Cortical thickness should also be evaluated. A study comparing cortical thickness between contralateral kidneys in 26 patients with unilateral RAS found significant differences in both cortical thickness and kidney length as assessed by CTA [82]. Furthermore, the technician and interpreting physician must be vigilant for the presence of unusual findings such as FMD, benign cysts or tumor. Fibromuscular dysplasia is suspected when peak systolic velocity is elevated in the mid or distal renal artery. In addition, a typical beaded appearance will suggest the medial fibroplasia variant of FMD. If present, the location, size and number of benign cysts should be documented [83]. Lack of flow within a cyst should be documented as opposed to tumor masses that may present with neovascularization or with echogenic material within the mass [84]. Any suspicion for tumor should prompt recommendation of a more sophisticated examination.
Conclusion
RADUS is an inexpensive, convenient and accurate method for assessing native, stented and transplant renal arteries for stenosis. While it has inherent limitations, it is the most commonly used tool for screening and surveillance of patients with RAS. Use of other imaging modalities and correlation with local outcomes should be utilized to corroborate RADUS findings prior to intervention.
References
Davis RP, Pearce JD, Craven TE, Moore PS, Edwards MS, Godshall CJ, Hansen KJ. Atherosclerotic renovascular disease among hypertensive adults. J Vasc Surg. 2009;50:564–70, 571.e1–3; discussion 571.
Rihal CS, Textor SC, Breen JF, McKusick MA, Grill DE, Hallett JW, Holmes Jr DR. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc. 2002;77:309–16.
Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor Jr LM, White CJ, White J, White RA, Antman EM, Smith Jr SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, American Association for Vascular Surgery, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease, American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute, Society for Vascular Nursing, TransAtlantic Inter-Society Consensus, Vascular Disease Foundation. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463–654.
Textor SC. Current approaches to renovascular hypertension. Med Clin North Am. 2009;93:717–32.
Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89:615–20.
Zoccali C, Mallamaci F, Finocchiaro P. Atherosclerotic renal artery stenosis: epidemiology, cardiovascular outcomes, and clinical prediction rules. J Am Soc Nephrol. 2002;13 Suppl 3:S179–83.
Williams GJ, Macaskill P, Chan SF, Karplus TE, Yung W, Hodson EM, Craig JC. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. AJR Am J Roentgenol. 2007;188:798–811.
Jose A, Kaplan NM. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension. Arch Intern Med. 1969;123:141–6.
Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431–42.
Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med. 2009;361:1972–8.
American College of Cardiology Foundation (ACCF), American College of Radiology (ACR), American Institute of Ultrasound in Medicine (AIUM), American Society of Echocardiography (ASE), American Society of Nephrology (ASN), Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Society for Interventional Radiology (SIR), Society for Vascular Medicine (SVM), Society for Vascular Surgery (SVS), Mohler 3rd ER, Gornik HL, Gerhard-Herman M, Misra S, Olin JW, Zierler RE, Wolk MJ, Mohler 3rd ER. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology Foundation appropriate use criteria task force, American College of Radiology, American Institute of Ultrasound in Medicine, American Society of Echocardiography, American Society of Nephrology, Intersocietal Commission for the Accreditation of Vascular Laboratories, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Am Coll Cardiol. 2012;60:242–76.
Drieghe B, Madaric J, Sarno G, Manoharan G, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur Heart J. 2008;29:517–24.
Weinberg I, Jaff MR. Nonatherosclerotic arterial disorders of the lower extremities. Circulation. 2012;126:213–22.
Pearce JD, Craven BL, Craven TE, Piercy KT, Stafford JM, Edwards MS, Hansen KJ. Progression of atherosclerotic renovascular disease: a prospective population-based study. J Vasc Surg. 2006;44:955–62; discussion 962–3.
Kawarada O, Yokoi Y, Morioka N, Takemoto K. Renal artery stenosis in cardio-and cerebrovascular disease: renal duplex ultrasonography as an initial screening examination. Circ J. 2007;71:1942–7.
Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg. 2002;36:443–51.
Edwards MS, Hansen KJ, Craven TE, Bleyer AJ, Burke GL, Levy PJ, Dean RH. Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study. Vasc Endovascular Surg. 2004;38:25–35.
Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness Jr DE. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866–72.
Zierler RE, Bergelin RO, Davidson RC, Cantwell-Gab K, Polissar NL, Strandness Jr DE. A prospective study of disease progression in patients with atherosclerotic renal artery stenosis. Am J Hypertens. 1996;9:1055–61.
Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E, American Society of Echocardiography, Society of Vascular Medicine and Biology. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr. 2006;19:943–54.
Hansen KJ, Tribble RW, Reavis SW, Canzanello VJ, Craven TE, Plonk Jr GW, Dean RH. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg. 1990;12:227–36.
Platt JF. Duplex Doppler evaluation of native kidney dysfunction: obstructive and nonobstructive disease. AJR Am J Roentgenol. 1992;158:1035–42.
Soares GM, Murphy TP, Singha MS, Parada A, Jaff M. Renal artery duplex ultrasonography as a screening and surveillance tool to detect renal artery stenosis: a comparison with current reference standard imaging. J Ultrasound Med. 2006;25:293–8.
Aburahma AF, Srivastava M, Mousa AY, Dearing DD, Hass SM, Campbell JR, Dean LS, Stone PA, Keiffer T. Critical analysis of renal duplex ultrasound parameters in detecting significant renal artery stenosis. J Vasc Surg. 2012;56(4):1052–9, 1060.e1; discussion 1059–60.
Kawarada O, Yokoi Y, Takemoto K, Morioka N, Nakata S, Shiotani S. The performance of renal duplex ultrasonography for the detection of hemodynamically significant renal artery stenosis. Catheter Cardiovasc Interv. 2006;68:311–8.
Conkbayir I, Yucesoy C, Edguer T, Yanik B, Yasar Ayaz U, Hekimoglu B. Doppler sonography in renal artery stenosis. An evaluation of intrarenal and extrarenal imaging parameters. Clin Imaging. 2003;27:256–60.
Nchimi A, Biquet JF, Brisbois D, Reginster P, Bouali K, Saive C, Magotteaux P. Duplex ultrasound as first-line screening test for patients suspected of renal artery stenosis: prospective evaluation in high-risk group. Eur Radiol. 2003;13:1413–9.
de Haan MW, Kroon AA, Flobbe K, Kessels AG, Tordoir JH, van Engelshoven JM, de Leeuw PW. Renovascular disease in patients with hypertension: detection with duplex ultrasound. J Hum Hypertens. 2002;16:501–7.
Ripolles T, Aliaga R, Morote V, Lonjedo E, Delgado F, Martinez MJ, Vilar J. Utility of intrarenal Doppler ultrasound in the diagnosis of renal artery stenosis. Eur J Radiol. 2001;40:54–63.
Voiculescu A, Hofer M, Hetzel GR, Malms J, Modder U, Grabensee B, Hollenbeck M. Noninvasive investigation for renal artery stenosis: contrast-enhanced magnetic resonance angiography and color Doppler sonography as compared to digital subtraction angiography. Clin Exp Hypertens. 2001;23:521–31.
Claudon M, Plouin PF, Baxter GM, Rohban T, Devos DM. Renal arteries in patients at risk of renal arterial stenosis: multicenter evaluation of the echo-enhancer SH U 508A at color and spectral Doppler US. Levovist Renal Artery Stenosis Study Group. Radiology. 2000;214:739–46.
Hua HT, Hood DB, Jensen CC, Hanks SE, Weaver FA. The use of colorflow duplex scanning to detect significant renal artery stenosis. Ann Vasc Surg. 2000;14:118–24.
Motew SJ, Cherr GS, Craven TE, Travis JA, Wong JM, Reavis SW, Hansen KJ. Renal duplex sonography: main renal artery versus hilar analysis. J Vasc Surg. 2000;32(462–9):469–71.
Radermacher J, Chavan A, Schaffer J, Stoess B, Vitzthum A, Kliem V, Rademaker J, Bleck J, Gebel MJ, Galanski M, Brunkhorst R. Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol. 2000;53:333–43.
Souza de Oliveira IR, Widman A, Molnar LJ, Fukushima JT, Praxedes JN, Cerri GG. Colour Doppler ultrasound: a new index improves the diagnosis of renal artery stenosis. Ultrasound Med Biol. 2000;26:41–7.
House MK, Dowling RJ, King P, Gibson RN. Using Doppler sonography to reveal renal artery stenosis: an evaluation of optimal imaging parameters. AJR Am J Roentgenol. 1999;173:761–5.
Kaplan-Pavlovcic S, Nadja C. Captopril renography and duplex Doppler sonography in the diagnosis of renovascular hypertension. Nephrol Dial Transplant. 1998;13:313–7.
Mollo M, Pelet V, Mouawad J, Mathieu JP, Branchereau A. Evaluation of colour duplex ultrasound scanning in diagnosis of renal artery stenosis, compared to angiography: a prospective study on 53 patients. Eur J Vasc Endovasc Surg. 1997;14:305–9.
Baxter GM, Aitchison F, Sheppard D, Moss JG, McLeod MJ, Harden PN, Love JG, Robertson M, Taylor G. Colour Doppler ultrasound in renal artery stenosis: intrarenal waveform analysis. Br J Radiol. 1996;69:810–5.
Burdick L, Airoldi F, Marana I, Giussani M, Alberti C, Cianci M, Lovaria A, Saccheri S, Gazzano G, Morganti A. Superiority of acceleration and acceleration time over pulsatility and resistance indices as screening tests for renal artery stenosis. J Hypertens. 1996;14:1229–35.
Miralles M, Cairols M, Cotillas J, Gimenez A, Santiso A. Value of Doppler parameters in the diagnosis of renal artery stenosis. J Vasc Surg. 1996;23:428–35.
Missouris CG, Allen CM, Balen FG, Buckenham T, Lees WR, MacGregor GA. Non-invasive screening for renal artery stenosis with ultrasound contrast enhancement. J Hypertens. 1996;14:519–24.
Helenon O, el Rody F, Correas JM, Melki P, Chauveau D, Chretien Y, Moreau JF. Color Doppler US of renovascular disease in native kidneys. Radiographics. 1995;15:833–54; discussion 854–65.
Olin JW, Piedmonte MR, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med. 1995;122:833–8.
Appel RG, Bleyer AJ, Hansen KJ. Duplex scanning of renal arteries for stenosis. Ann Intern Med. 1996;124:370–1.
Kliewer MA, Tupler RH, Carroll BA, Paine SS, Kriegshauser JS, Hertzberg BS, Svetkey LP. Renal artery stenosis: analysis of Doppler waveform parameters and tardus-parvus pattern. Radiology. 1993;189:779–87.
Stavros AT, Parker SH, Yakes WF, Chantelois AE, Burke BJ, Meyers PR, Schenck JJ. Segmental stenosis of the renal artery: pattern recognition of tardus and parvus abnormalities with duplex sonography. Radiology. 1992;184:487–92.
Antonica G, Sabba C, Berardi E, Buonamico P, Paolo C, Vulpis V, Ettorre G, Pirrelli A, Albano O. Accuracy of echo-Doppler flowmetry for renal artery stenosis. J Hypertens Suppl. 1991;9:S240–1.
Hoffmann U, Edwards JM, Carter S, Goldman ML, Harley JD, Zaccardi MJ, Strandness Jr DE. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int. 1991;39:1232–9.
Hawkins PG, McKnoulty LM, Gordon RD, Klemm SA, Tunny TJ. Non-invasive renal artery duplex ultrasound and computerized nuclear renography to screen for and follow progress in renal artery stenosis. J Hypertens Suppl. 1989;7:S184–5.
Taylor DC, Kettler MD, Moneta GL, Kohler TR, Kazmers A, Beach KW, Strandness Jr DE. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg. 1988;7:363–9.
Avasthi PS, Voyles WF, Greene ER. Noninvasive diagnosis of renal artery stenosis by echo-Doppler velocimetry. Kidney Int. 1984;25:824–9.
White CJ. Optimizing outcomes for renal artery intervention. Circ Cardiovasc Interv. 2010;3:184–92.
Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410–7.
Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn HP, Cook-Bruns N, Neumann FJ. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244–9.
Riehl J, Schmitt H, Bongartz D, Bergmann D, Sieberth HG. Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol Dial Transplant. 1997;12:1608–14.
Schwerk WB, Restrepo IK, Stellwaag M, Klose KJ, Schade-Brittinger C. Renal artery stenosis: grading with image-directed Doppler US evaluation of renal resistive index. Radiology. 1994;190:785–90.
Radermacher J, Mengel M, Ellis S, Stuht S, Hiss M, Schwarz A, Eisenberger U, Burg M, Luft FC, Gwinner W, Haller H. The renal arterial resistance index and renal allograft survival. N Engl J Med. 2003;349:115–24.
Bardelli M, Jensen G, Volkmann R, Aurell M. Non-invasive ultrasound assessment of renal artery stenosis by means of the Gosling pulsatility index. J Hypertens. 1992;10:985–9.
Barozzi L, Pavlica P, Sabattini A, Losinno F, Dondi M, De Fabritiis A, Amato A, Zuccala A. Duplex and Doppler color echocardiography for the study of renovascular hypertension. Comparison with arteriography. Radiol Med. 1991;81:642–9.
Manganaro A, Ando’ G, Salvo A, Consolo A, Coppolino F, Giannino D. A comparison of Power Doppler with conventional sonographic imaging for the evaluation of renal artery stenosis. Cardiovasc Ultrasound. 2004;2:1.
Tola M, Yurdakul M, Ozbulbul NI. B-flow imaging for the measurement of residual lumen diameter of renal artery stenosis. J Clin Ultrasound. 2012;40:85–90.
Saeed A, Bergstrom G, Zachrisson K, Guron G, Nowakowska-Fortuna E, Fredriksen E, Lonn L, Jensen G, Herlitz H. Accuracy of colour duplex sonography for the diagnosis of renal artery stenosis. J Hypertens. 2009;27:1690–6.
Fleming SH, Davis RP, Craven TE, Deonanan JK, Godshall CJ, Hansen KJ. Accuracy of duplex sonography scans after renal artery stenting. J Vasc Surg. 2010;52:953–7; discussion 958.
Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011;53:826–36.e1.
Das CJ, Neyaz Z, Thapa P, Sharma S, Vashist S. Fibromuscular dysplasia of the renal arteries: a radiological review. Int Urol Nephrol. 2007;39:233–8.
Bakker J, Beutler JJ, Elgersma OE, de Lange EE, de Kort GA, Beek FJ. Duplex ultrasonography in assessing restenosis of renal artery stents. Cardiovasc Intervent Radiol. 1999;22:475–80.
Rocha-Singh K, Jaff MR, Lynne Kelley E, RENAISSANCE Trial Investigators. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv. 2008;72:853–62.
Chi YW, White CJ, Thornton S, Milani RV. Ultrasound velocity criteria for renal in-stent restenosis. J Vasc Surg. 2009;50:119–23.
Mohabbat W, Greenberg RK, Mastracci TM, Cury M, Morales JP, Hernandez AV. Revised duplex criteria and outcomes for renal stents and stent grafts following endovascular repair of juxtarenal and thoracoabdominal aneurysms. J Vasc Surg. 2009;49:827–37; discussion 837.
Browne RF, Tuite DJ. Imaging of the renal transplant: comparison of MRI with duplex sonography. Abdom Imaging. 2006;31:461–82.
Gao J, Li JC, Xiao MS, Ng A, Trost D, Goldstein M, Kapur S, Wang J, Serur D, Dai Q, Jiang YX, Min RJ. Color duplex sonography in severe transplant renal artery stenosis: a comparison of end-to-end and end-to-side arterial anastomoses. Clin Imaging. 2009;33:116–22.
de Morais RH, Muglia VF, Mamere AE, Garcia Pisi T, Saber LT, Muglia VA, Elias Jr J, Piccinato CE, Trad CS. Duplex Doppler sonography of transplant renal artery stenosis. J Clin Ultrasound. 2003;31:135–41.
Loubeyre P, Abidi H, Cahen R, Tran Minh VA. Transplanted renal artery: detection of stenosis with color Doppler US. Radiology. 1997;203:661–5.
Erley CM, Duda SH, Wakat JP, Sokler M, Reuland P, Muller-Schauenburg W, Schareck W, Lauchart W, Risler T. Noninvasive procedures for diagnosis of renovascular hypertension in renal transplant recipients–a prospective analysis. Transplantation. 1992;54:863–7.
Baxter GM, Ireland H, Moss JG, Harden PN, Junor BJ, Rodger RS, Briggs JD. Colour Doppler ultrasound in renal transplant artery stenosis: which Doppler index? Clin Radiol. 1995;50:618–22.
Montanes Medina P, Medina Lopez RA, Torrubia Romero FJ, Dominguez Anguiano M, Cruz Navarro N, Rus Herrera F, Munoz Terol J, Rocha Castilla JL. Renal artery stenosis in the transplant patient. Arch Esp Urol. 1999;52:771–6.
Li JC, Ji ZG, Cai S, Jiang YX, Dai Q, Zhang JX. Evaluation of severe transplant renal artery stenosis with Doppler sonography. J Clin Ultrasound. 2005;33:261–9.
Gottlieb RH, Lieberman JL, Pabico RC, Waldman DL. Diagnosis of renal artery stenosis in transplanted kidneys: value of Doppler waveform analysis of the intrarenal arteries. AJR Am J Roentgenol. 1995;165:1441–6.
Guzman RP, Zierler RE, Isaacson JA, Bergelin RO, Strandness Jr DE. Renal atrophy and arterial stenosis. A prospective study with duplex ultrasound. Hypertension. 1994;23:346–50.
Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, Casadei A, Davidson RC, Strandness Jr DE. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735–42.
Mounier-Vehier C, Lions C, Devos P, Jaboureck O, Willoteaux S, Carre A, Beregi JP. Cortical thickness: an early morphological marker of atherosclerotic renal disease. Kidney Int. 2002;61:591–8.
de Bruyn R, Gordon I. Imaging in cystic renal disease. Arch Dis Child. 2000;83:401–7.
Kier R, Taylor KJ, Feyock AL, Ramos IM. Renal masses: characterization with Doppler US. Radiology. 1990;176:703–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Weinberg, I., Jaff, M.R. (2014). Renal Artery Duplex Ultrasonography. In: Lerman, L., Textor, S. (eds) Renal Vascular Disease. Springer, London. https://doi.org/10.1007/978-1-4471-2810-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2810-6_12
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2809-0
Online ISBN: 978-1-4471-2810-6
eBook Packages: MedicineMedicine (R0)